Lymphatica Medtech
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $20M
Investors
- 9
About Lymphatica Medtech
Founded in 2017 and headquartered in Lausanne, Switzerland, Lymphatica Medtech SA focuses on developing advanced medical devices for lymphatic health.9 million.Lymphatica Medtech specializes in innovative medical devices designed to enhance lymphatic health and facilitate drainage. Their primary products are advanced systems for clinical and home use, addressing lymphedema and chronic venous insufficiency. Utilizing pneumatic compression technology, these devices promote fluid movement within the lymphatic system, alleviating swelling and discomfort.Lymphatica Medtech generates revenue through direct sales and partnerships with healthcare providers and distributors. Their business model is primarily B2B, where medical institutions purchase devices for patient treatment, including bulk orders and tailored pricing plans. The company’s products are marketed under distinct branding, ensuring marketplace recognition, while their competitive pricing strategy makes them accessible to both institutional clients and individual consumers seeking home-use devices. Lymphatica aims to design and launch new products targeting the growing demand for lymphatic health solutions and plans to expand into additional European and North American markets by 2025.
Who invested in Lymphatica Medtech
9 investors across 2 rounds
See all investors in Lymphatica Medtech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lymphatica Medtech
Who invested in Lymphatica Medtech?
Lymphatica Medtech has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lymphatica Medtech raised?
Lymphatica Medtech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lymphatica Medtech last raise money?
Lymphatica Medtech's most recent round on record is a Series B, in Oct 2024.
What does Lymphatica Medtech do?
Founded in 2017 and headquartered in Lausanne, Switzerland, Lymphatica Medtech SA focuses on developing advanced medical devices for lymphatic health.
Where is Lymphatica Medtech headquartered?
Lymphatica Medtech is headquartered in Lausanne, Switzerland.
Which VCs invest in companies like Lymphatica Medtech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Lymphatica Medtech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Lymphatica Medtech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.